Evidence map›Paper›PMID 34869462›Full record

ArticleFrontiers in medicine2021

Does Cannabis Extract Obtained From Cannabis Flowers With Maximum Allowed Residual Level of Aflatoxins and Ochratoxin a Have an Impact on Human Safety and Health?

Tijana Serafimovska, Sasho Stefanovski, Joachim Erler, Zlatko Keskovski, Gjoshe Stefkov, Marija Mitevska, Marija Darkovska Serafimovska, Trajan Balkanov, Jasmina Tonic Ribarska

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Tijana SerafimovskaFaculty of Pharmacy, University Ss. Cyril and Methodius, Skopje, North Macedonia.
Sasho StefanovskiNYSK Holdings, Company for Growing, Extraction and Producing of Pharmaceutical Dosage Forms of Medical Cannabis, Skopje, North Macedonia.
Joachim ErlerDiapharm GmbH & Co. KG, Münster, Germany.
Zlatko KeskovskiNYSK Holdings, Company for Growing, Extraction and Producing of Pharmaceutical Dosage Forms of Medical Cannabis, Skopje, North Macedonia.
Gjoshe StefkovFaculty of Pharmacy, University Ss. Cyril and Methodius, Skopje, North Macedonia.
Marija MitevskaNYSK Holdings, Company for Growing, Extraction and Producing of Pharmaceutical Dosage Forms of Medical Cannabis, Skopje, North Macedonia.
Marija Darkovska SerafimovskaFaculty of Medical Sciences, University Goce Delcev, Shtip, North Macedonia.
Trajan BalkanovDepartment of Pharmacology and Toxicology, Faculty of Medicine, University Ss. Cyril and Methodius, Skopje, North Macedonia.
Jasmina Tonic RibarskaFaculty of Pharmacy, University Ss. Cyril and Methodius, Skopje, North Macedonia.
Saints Cyril and Methodius University of Skopje · MKAgency for Electronic Communications · MKGoce Delcev University · MK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

aflatoxinscannabis extractsdetermination liquid chromatography with tandem mass spectrometry (LC/MS/MS)mycotoxinsochratoxin A

Identifiers

PMID34869462
PMCPMC8634097
OpenAlexW3213455867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.